The Increasing Incidence of Chronic Respiratory Conditions is Driving Global Smart Inhalers Market

The global smart inhalers market stands at the forefront of a transformative era in healthcare, where innovation converges with respiratory care, and redefining traditional approaches to managing chronic conditions like asthma and COPD (Chronic Obstructive Pulmonary Disease). These cutting-edge devices, equipped with sensors and connectivity features, represent a paradigm shift in how patients monitor and administer their medications. With the increasing prevalence of respiratory disorders and a growing emphasis on personalized healthcare, the smart inhalers market has emerged as a beacon of hope, promising improved adherence, better management, and enhanced patient outcomes. As technology continues to evolve, smart inhalers pave the way for a future where the intersection of medicine and innovation creates a more empowered, informed, and connected approach to respiratory health.

What are smart inhalers?

A smart inhaler is one that blends connection with a mobile app, such as Bluetooth. These gadgets employ sensor technology to collect data regarding the time and date of usage, as well as the patient’s location at each use. Teva’s ProAir Digihaler (albuterol sulphate), which features a use-tracking real-time sensor that syncs with a mobile app, was the world’s first smart inhaler to earn FDA clearance. Several new clip-on devices are being developed, including those from the United States-based Propeller Health and New Zealand-based Adherium.

Future of Global Smart Inhalers Market

The future of the global smart inhalers market appears promising, driven by technological innovation, a shift towards patient-centric care, and a collaborative ecosystem aiming to revolutionize respiratory healthcare. As these devices continue to evolve and overcome existing barriers, they are poised to play an increasingly integral role in improving the management and quality of life for individuals with respiratory conditions worldwide. Besides the growing preference for remote healthcare services will fuel the demand for smart inhalers, facilitating remote patient monitoring. These devices enable healthcare professionals to remotely track patient adherence and health status, allowing for timely interventions and personalized adjustments in treatment plans, regardless of geographical barriers.

In 2022, asthma had the highest share in the global smart inhalers as asthma is one of the common respiratory disorders across various regions. For asthma patients, smart inhalers help in delivering the prescribed medication accurately, tracking usage, and reminding patients about their dosage schedules. They also assist in monitoring environmental factors or triggers that might exacerbate asthma symptoms.

North America, particularly the United States, leads in smart inhalers adoption due to advanced healthcare infrastructure, high awareness, and favorable reimbursement policies. While on the other hand, countries like China and India are witnessing growing adoption rates of smart inhalers due to urbanization, lifestyle changes, and an emphasis on healthcare innovation.

Global Smart Inhalers Market: Competitive Scenario

  • adherium
  • AptarGroup, Inc.
  • Cognita Labs, LLC
  • GSK plc
  • Novartis AG
  • Opko Health Inc.
  • Philip Morris Products S.A.
  • Questex LLC
  • ResMed
  • Teva Pharmaceutical Industries Ltd.
  • Other Industry Participants

Global Smart Inhalers Market:

By Product

  • Dry Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)

By Indication

  • Asthma
  • COPD

By Sales Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Leave a Comment

Your email address will not be published. Required fields are marked *

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top